The reclassification of cannabis to Schedule III would acknowledge its accepted medical use and lower potential for abuse compared to Schedule I substances. This shift would bring cannabis more in line with other prescription medications, necessitating rigorous standards for quality control and safety. For cannabis testing labs and product... Read more
Cannabis dispensaries face unique challenges in maintaining security while ensuring a seamless customer experience. Efficiently moving products from the vault to the retail floor is crucial for both operational efficiency and security. According to a report, theft at cannabis dispensaries has surged by over 30% in recent years, underscoring... Read more
CBD Oracle’s combined analysis of 70 polls shows a decade of increasing support for legal cannabis, with 62% of Americans supporting legalization in 2024. How many Americans support legalizing cannabis? You might think this is easy to answer: you find the most recent poll and look up the number.... Read more
With several states going legal ahead of them, New York State regulators had the benefit of watching other states develop testing programs, which is why New York’s testing regiment goes beyond many of the early adopter states to be one of the most stringent in the nation. And while... Read more
There is no hotter pre roll market in the country than Michigan. With an average unit price of $6.16 – one of the lowest in the country, according to cannabis analytics firm Headset – retailers have sold more than 56.7 million units for a total of more than $349.8... Read more
As the cannabis industry continues to grow, businesses face unique challenges, particularly in Human Resources. One critical, yet often overlooked aspect, is the creation and maintenance of clear, effective job descriptions. At Deliberate HR, we understand the well-crafted job descriptions are more than just a formality- they are essential... Read more
Welcome back to the unfolding chapters of our Cannabis Risk Management series. In our preceding blogs, we intricately explored the risks woven into cultivation and the dynamic challenges faced by the retail sector. Now, our compass directs us towards the distribution sector, where the landscape extends far beyond the... Read more
This summer, Cannabis NewsHub reached out to successful leaders in the cannabis community to get their thoughts on the possible rescheduling of Cannabis and its impact. INSIGHTS Matter: 280E asked them to share their insights and advice on this question: If cannabis is reclassified as a Schedule III drug, Section... Read more
Access the full recording of our insightful webinar, “Redefining Cannabis Marketing,” and discover how to navigate the evolving landscape of cannabis marketing and advertising post-rescheduling. In this pivotal episode, the Marketing & Advertising Committee collaborates with the State Regulations Committee to explore the potential impact of cannabis transitioning to... Read more
Access the full recording of our insightful webinar, “Rescheduled Realities,” and explore the transformative impact of cannabis rescheduling to Schedule III on the manufacturing sector. In this fifth installment of NCIA’s #IndustryEssentials multi-part webinar series, our expert Cannabis Manufacturing Committee delves into the major shifts and implications following the... Read more
